128 related articles for article (PubMed ID: 29784192)
1. Differential Gene Expression in Prostate Tissue According to Ejaculation Frequency.
Sinnott JA; Brumberg K; Wilson KM; Ebot EM; Giovannucci EL; Mucci LA; Rider JR
Eur Urol; 2018 Nov; 74(5):545-548. PubMed ID: 29784192
[TBL] [Abstract][Full Text] [Related]
2. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up.
Rider JR; Wilson KM; Sinnott JA; Kelly RS; Mucci LA; Giovannucci EL
Eur Urol; 2016 Dec; 70(6):974-982. PubMed ID: 27033442
[TBL] [Abstract][Full Text] [Related]
3. Gene expression in normal-appearing tissue adjacent to prostate cancers are predictive of clinical outcome: evidence for a biologically meaningful field effect.
Magi-Galluzzi C; Maddala T; Falzarano SM; Cherbavaz DB; Zhang N; Knezevic D; Febbo PG; Lee M; Lawrence HJ; Klein EA
Oncotarget; 2016 Jun; 7(23):33855-65. PubMed ID: 27121323
[TBL] [Abstract][Full Text] [Related]
4. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease.
Van Den Eeden SK; Lu R; Zhang N; Quesenberry CP; Shan J; Han JS; Tsiatis AC; Leimpeter AD; Lawrence HJ; Febbo PG; Presti JC
Eur Urol; 2018 Jan; 73(1):129-138. PubMed ID: 28988753
[TBL] [Abstract][Full Text] [Related]
5. Ejaculation frequency and subsequent risk of prostate cancer.
Leitzmann MF; Platz EA; Stampfer MJ; Willett WC; Giovannucci E
JAMA; 2004 Apr; 291(13):1578-86. PubMed ID: 15069045
[TBL] [Abstract][Full Text] [Related]
6. Identifying molecular features for prostate cancer with Gleason 7 based on microarray gene expression profiles.
Bălăcescu L; Bălăcescu O; Crişan N; Fetica B; Petruţ B; Bungărdean C; Rus M; Tudoran O; Meurice G; Irimie A; Dragoş N; Berindan-Neagoe I
Rom J Morphol Embryol; 2011; 52(4):1195-202. PubMed ID: 22203922
[TBL] [Abstract][Full Text] [Related]
7. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection.
Gregg JL; Brown KE; Mintz EM; Piontkivska H; Fraizer GC
BMC Cancer; 2010 Apr; 10():165. PubMed ID: 20426842
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression Pathways in Prostate Tissue Associated with Vigorous Physical Activity in Prostate Cancer.
Pernar CH; Parmigiani G; Giovannucci EL; Rimm EB; Tyekucheva S; Loda M; Finn SP; Vander Heiden MG; Fiorentino M; Ebot EM; Mucci LA
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):751-756. PubMed ID: 33500320
[TBL] [Abstract][Full Text] [Related]
9. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors.
Chandran UR; Dhir R; Ma C; Michalopoulos G; Becich M; Gilbertson J
BMC Cancer; 2005 May; 5():45. PubMed ID: 15892885
[TBL] [Abstract][Full Text] [Related]
10. Comparing Prognostic Utility of a Single-marker Immunohistochemistry Approach with Commercial Gene Expression Profiling Following Radical Prostatectomy.
Leapman MS; Nguyen HG; Cowan JE; Xue L; Stohr B; Simko J; Cooperberg MR; Carroll PR
Eur Urol; 2018 Nov; 74(5):668-675. PubMed ID: 30181067
[TBL] [Abstract][Full Text] [Related]
11. Realizing the potential of ejaculate/seminal fluid in detecting and predicting natural history.
Gardiner RA; Burger M; Clements JA; Lavin MF
Methods Mol Med; 2003; 81():199-217. PubMed ID: 12725122
[No Abstract] [Full Text] [Related]
12. Gene expression profiling of prostate tissue identifies chromatin regulation as a potential link between obesity and lethal prostate cancer.
Ebot EM; Gerke T; Labbé DP; Sinnott JA; Zadra G; Rider JR; Tyekucheva S; Wilson KM; Kelly RS; Shui IM; Loda M; Kantoff PW; Finn S; Vander Heiden MG; Brown M; Giovannucci EL; Mucci LA
Cancer; 2017 Nov; 123(21):4130-4138. PubMed ID: 28700821
[TBL] [Abstract][Full Text] [Related]
13. Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.
Mostaghel EA; Geng L; Holcomb I; Coleman IM; Lucas J; True LD; Nelson PS
Cancer Res; 2010 Feb; 70(4):1286-95. PubMed ID: 20124490
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
[TBL] [Abstract][Full Text] [Related]
15. Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
Schlicht M; Matysiak B; Brodzeller T; Wen X; Liu H; Zhou G; Dhir R; Hessner MJ; Tonellato P; Suckow M; Pollard M; Datta MW
BMC Genomics; 2004 Aug; 5(1):58. PubMed ID: 15318950
[TBL] [Abstract][Full Text] [Related]
16. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
[TBL] [Abstract][Full Text] [Related]
17. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
18. Shared gene expression alterations in prostate cancer and histologically benign prostate from patients with prostate cancer.
Kosari F; Cheville JC; Ida CM; Karnes RJ; Leontovich AA; Sebo TJ; Erdogan S; Rodriguez E; Murphy SJ; Vasmatzis G
Am J Pathol; 2012 Jul; 181(1):34-42. PubMed ID: 22640805
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array.
Chetcuti A; Margan S; Mann S; Russell P; Handelsman D; Rogers J; Dong Q
Prostate; 2001 May; 47(2):132-40. PubMed ID: 11340636
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.
O'Hurley G; Busch C; Fagerberg L; Hallström BM; Stadler C; Tolf A; Lundberg E; Schwenk JM; Jirström K; Bjartell A; Gallagher WM; Uhlén M; Pontén F
PLoS One; 2015; 10(8):e0133449. PubMed ID: 26237329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
